Seronegative neuromyelitis optica: Improvement following lymphocytapheresis

Multiple Sclerosis

Volumn 14, Issue 6, 2008, Pages 860-861

  Moreh, E ^a   Gartsman, I ^a   Karussis, D ^a   Rund, D ^a   Hiller, N ^a   Meiner, Z ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE SODIUM SUCCINATE; PLASMA SUBSTITUTE; PREDNISOLONE; RITUXIMAB;

ADULT; BRAIN DAMAGE; BRAIN SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; CYTAPHERESIS; DAILY LIFE ACTIVITY; DISEASE DURATION; DRUG MEGADOSE; FECES INCONTINENCE; FEMALE; HUMAN; LEG PAIN; LETTER; LYMPHOCYTAPHERESIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; REHABILITATION CARE; THERAPY RESISTANCE; TREATMENT DURATION; TREATMENT RESPONSE; URINE INCONTINENCE; WALKING AID;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; LEUKAPHERESIS; MAGNETIC RESONANCE IMAGING; NEUROMYELITIS OPTICA;

EID: 48349117855     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508088943     Document Type: Letter

References (9)

1. Wingerchuk, DM, Lennon, VA, Pittock, SJ, Lucchinetti, CF, Weinshenker, BG. Revised diagnostic criteria. for neuromyelitis optica. Neurology 2006; 66: 1485-4489.
2. Lennon, VA, Wingerchuk, DM, Kryzer, TJ, Pittock, SJ, Lucchinetti, CF, Fujihara, K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
3. Lucchinetti, CF, Mandler, RN, McGavern, D, Bruck, W, Gleich, G, Ransohoff, RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-1461.
4. Watanabe, S, Nakashima, I, Misu, T, Miyazawa, I, Shiga, Y, Fujihara, K, Itoyama, Y. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007; 13: 128-132.
5. Nozaki, I, Hamaguchi, T, Komai, K, Yamada, M. Fulminant Devic disease successfully treated by lymphocytapheresis. J Neurol Neurosurg Psychiatry 2006; 77: 1094-1095.
6. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.
7. Cree, BA, Lamb, S, Morgan, K, Chen, A, Waubant, E, Genain, C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005; 64: 1270-1272.
8. Mandler, RN, Ahmed, W, Dencoff, JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998; 51: 1219-1220.
9. Aguilera, AJ, Carlow, TJ, Smith, KJ, Simon, TL. Lymphocytaplasmapheresis in Devic's syndrome. Transfusion 1985; 25: 54-56.